Back

Impact of pulmonary vein variant anatomy during cryo-ablation in paroxysmal and persistent AF patients: 1-year outcome from a nationwide multicenter clinical setting

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Poster session on devices, others Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Massimo Moltrasio

Monzino Cardiology Centre, Milan (Italy)

108 More presentations in this session

Presentation thumbnail
Emergency leadless pacing implantation is feasible and safe out-of-hours
Doctor F. O'Rourke (London, GB)
Abstract Slides Video
Presentation thumbnail
Outcomes of subcutaneous implantable cardioverter defibrillators: UK tertiary centre experience
Doctor L. Toon (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of the quality of life of patients with leadless pacing system during 1 year follow-up period
Doctor A. Baimbetov (Almaty, KZ)
Abstract Slides
Presentation thumbnail
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?
Mr C. Israel (Bielefeld, DE)
Abstract Slides Video
Presentation thumbnail
Procedural heart rate variability and its effect on short-term symptoms after cardioneuromodulation procedure
Doctor S. AYGUN (Ankara, TR)
Abstract

Access the full session

Session thumbnail
Poster session on devices, others

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Pulmonary veins anatomy variants and cryoballoon ablation for atrial fibrillation
thumbnail
Congress Presentation
Feasibility and efficacy assessment of a novel size-adjustable cryoballoon for ablation of atrial fibrillation in a multicenter clinical setting
thumbnail
Congress Presentation
Very long-term follow-up of pulmonary vein isolation using cryoballoon for catheter ablation for atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources